GENMAB A/S -SP ADR (GMAB:NASDAQ)
$37.37 0.3 (0.8093%)
Analysed GENMAB A/S -SP ADR (GMAB:NASDAQ) News Sources
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
06-10-2026
biopharmadive.com
AbbVie (ABBV) Cut Frontline DLBCL Progression Or Death Risk By 51%
07-10-2026
yahoo.com
Genmab Announces Rinatabart Sesutecan (Rina-S®) Phase 2 RAINFOL™-01 Results Demonstrated Durable and Clinically Meaningful Responses in Patients with Platinum-Resistant Ovarian Cancer
03-10-2026
yahoo.com
Genmab shares jump as ovarian cancer drug shows durable responses in trial
05-10-2026
yahoo.com
Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
05-10-2026
yahoo.com
AbbVie and Genmab Announce Epcoritamab in Combination with R-CHOP Demonstrates Significant Improvement in Progression-Free Survival versus R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
05-10-2026
yahoo.com
AbbVie Partner Flies Sky-High On News For Its $3 Billion Cancer Contender
05-10-2026
yahoo.com
Strength Seen in Genmab (GMAB): Can Its 10.7% Jump Turn into More Strength?
06-10-2026
yahoo.com
Genmab jumps as its lymphoma drug combo with AbbVie cuts progression, death risk
06-10-2026
yahoo.com
Genmab (CPSE:GMAB) Posts Two Strong Trial Readouts, Is The Valuation Now Too Hard To Ignore?
07-10-2026
yahoo.com
What is the current price of GENMAB A/S -SP ADR (GMAB:NASDAQ)?
The current price of GENMAB A/S -SP ADR (GMAB:NASDAQ) is $37.37.
GENMAB A/S -SP ADR (GMAB:NASDAQ) absolute price change since previous trading day?
The absolute price change of GENMAB A/S -SP ADR (GMAB:NASDAQ) since the previous trading day is $0.3.
GENMAB A/S -SP ADR (GMAB:NASDAQ) percentage price change since previous trading day?
The percentage price change of GENMAB A/S -SP ADR (GMAB:NASDAQ) since the previous trading day is 0.8093%.
What is the most recent average sentiment score for GENMAB A/S -SP ADR (GMAB:NASDAQ)?
The most recent average sentiment score for GENMAB A/S -SP ADR (GMAB:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for GENMAB A/S -SP ADR (GMAB:NASDAQ)?
The most recent sentiment for GENMAB A/S -SP ADR (GMAB:NASDAQ) is .
SEC-8K** Filing Available For GENMAB A/S -SP ADR (GMAB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.